Cambridge Investment Research Advisors, Inc. Organon & Co. Transaction History
Cambridge Investment Research Advisors, Inc.
- $26 Billion
- Q1 2024
A detailed history of Cambridge Investment Research Advisors, Inc. transactions in Organon & Co. stock. As of the latest transaction made, Cambridge Investment Research Advisors, Inc. holds 38,710 shares of OGN stock, worth $779,619. This represents 0.0% of its overall portfolio holdings.
Number of Shares
38,710
Previous 19,977
93.77%
Holding current value
$779,619
Previous $288,000
152.78%
% of portfolio
0.0%
Previous 0.0%
Shares
12 transactions
Others Institutions Holding OGN
# of Institutions
789Shares Held
190MCall Options Held
2.46MPut Options Held
2.27M-
Black Rock Inc. New York, NY33.5MShares$675 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA30.8MShares$620 Million0.01% of portfolio
-
Massachusetts Financial Services CO Boston, MA10.2MShares$204 Million0.06% of portfolio
-
State Street Corp Boston, MA9.3MShares$187 Million0.01% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il6.18MShares$124 Million0.02% of portfolio
About Organon & Co.
- Ticker OGN
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 254,330,000
- Market Cap $5.12B
- Description
- Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...